Page 1 | Search Results | Blood | American Society of Hematology

1-14 of 14

Sort by

Sort Order Select

Journal Articles

Pediatric Patients with Relapsed/Refractory Acute Lymphoblastic Leukemia Harboring Heterogeneous Genomic Profiles Respond to Venetoclax in Combination with Chemotherapy

Andrew E. Place, MDPhD, Seth E. Karol, MD, Christopher J. Forlenza, MD, Marion Gambart, MD, Todd M. Cooper, DO, Christopher Fraser, MBBS, Gunnar Cario, MD PhD, Maureen M O'Brien, MD, Nicolas U. Gerber, MD, Phillip Barnette, MD, Dirk Reinhardt, MDPhD, Giridharan Ramsingh, MD, Bo Tong, PhD, Kristina Unnebrink, PhD, Deeksha Vishwamitra, PhD, Fengjiao Dunbar, PhD, Betty A. Prine, BS, Tammy L. Palenski, PhD, Mignon L. Loh, MD

Blood (2020) 136 (Supplement 1): 37–38.

https://doi.org/10.1182/blood-2020-137376

Published: 2020

Journal Articles

Pegylated E. coli Asparaginase Desensitization: An Effective and Feasible Option for Pediatric Patients with Acute Lymphoblastic Leukemia Who Have Developed Hypersensitivity to Pegaspargase in the Absence of Asparaginase Erwinia Chrysanthemi availability

Anupam Verma, MD, Karin Chen, MD, Jacob Johnsen, PharmD, Phillip Barnette, MD

Blood (2018) 132 (Supplement 1): 5205.

https://doi.org/10.1182/blood-2018-99-119866

Published: 2018

Journal Articles

CA180-372: An International Collaborative Phase 2 Trial of Dasatinib and Chemotherapy in Pediatric Patients with Newly Diagnosed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ ALL)

Blood (2017) 130 (Supplement 1): 98.

https://doi.org/10.1182/blood.V130.Suppl_1.98.98

Published: 2017

Journal Articles

Initial Results from a Phase 2 Study of Blinatumomab in Pediatric Patients with Relapsed/Refractory B-Cell Precursor Acute Lymphoblastic Leukemia

Blood (2014) 124 (21): 3703.

https://doi.org/10.1182/blood.V124.21.3703.3703

Published: 2014

Journal Articles

IKZF1 and 22q11.22 Deletions and PDGFRA Gains Are Associated with Poor Outcome in Down Syndrome Acute Lymphoblastic Leukemia

Blood (2012) 120 (21): 289.

https://doi.org/10.1182/blood.V120.21.289.289

Published: 2012

Journal Articles

Interim Report of a Randomized, Open-Label, Multicenter Study to Evaluate the Safety and Efficacy of Decitabine As an Epigenetic Priming Agent When Combined with Induction Chemotherapy in Pediatric Patients (pts) with Newly Diagnosed Acute Myelogenous Leukemia (AML)

Lia Gore, MD, Margaret E. Macy, M.D., Francoise Mechinaud, MD, Aru Narendran, MD, PhD, Frank Alvaro, MD, Carola A.S. Arndt, MD, Phillip Barnette, MD, Jessica Boklan, MD, Todd Cooper, DO, Laura Martin, MD, W Tcheng, MD, Peter Tarassoff, MD, Mark M Jones, MD, Soheil Meshinchi, MD, PhD, Robert J. Arceci, MD, PhD

Blood (2012) 120 (21): 1517.

https://doi.org/10.1182/blood.V120.21.1517.1517

Published: 2012

Journal Articles

PTEN Expression Is Decreased in Pediatric Burkitt Lymphoma Tissues but Does Not Correlate with AKT Activation.

Rodic Vladimir, Tripp Sheryl, Michael G Bayerl, MD, Phillip Barnette, MD, Joshua D. Schiffman, MD, Sherrie L. Perkins, MD, PhD, Rodney R. Miles, MD, PhD

Blood (2012) 120 (21): 2664.

https://doi.org/10.1182/blood.V120.21.2664.2664

Published: 2012

Journal Articles

Focal 22q11.22 Loss Combined with IKZF1 Alterations Predict Very Poor Outcome in Childhood Acute Lymphoblastic Leukemia

D. Spencer Mangum, MD, Soheil Shams, PhD, Jonathan M. Downie, BS, Uta von Schwedler, PhD, Vladimir Rodic, PhD, Michael Engel, MD, PhD, Phillip Barnette, MD, J. Kimble Frazer, MD, PhD, Nikolaus Trede, MD, PhD, Dequing Pei, PhD, Cheng Cheng, PhD, Ching-Hon Pui, MD, Stephen P Hunger, MD, Jun J. Yang, PhD, Rodney R. Miles, MD, PhD, Charles G Mullighan, MBBS, MD, FRACP, FRCPA, MSc, Joshua D. Schiffman, MD

Blood (2011) 118 (21): 741.

https://doi.org/10.1182/blood.V118.21.741.741

Published: 2011

Journal Articles

T-Cell Receptor Gene Deletions Are Associated with High Risk Features and Worse Outcome In Childhood Precursor B-Cell Acute Lymphoblastic Leukemia (ALL)

Jonathan Downie, BS, Phillip Barnette, MD, Vladimir Rodic, BS, J. Kimble Frazer, MD, PhD, Nikolaus Trede, MD, PhD, Meenakshi Devidas, PhD, Charles Mullighan, MBBS, MD, FRACP, FRCPA, MSc, Stephen Hunger, MD, Rodney R. Miles, MD, PhD, Joshua D. Schiffman, MD

Blood (2010) 116 (21): 275.

https://doi.org/10.1182/blood.V116.21.275.275

Published: 2010

Journal Articles

VPREB1 Deletions Occur Independent of Lambda-Light Chain Rearrangement and Predict Worse Outcome In Pediatric Acute Lymphoblastic Leukemia (ALL)

Rodney R. Miles, MD, PhD, Jonathan Downie, BS, Mona S. Jahromi, BS, Deepa Joshi, BS, Vladimir Rodic, BS, Markus Muschen, MD, Jun J. Yang, PhD, William E. Evans, PharmD, Nathan Meeker, MD, Nikolaus Trede, MD, PhD, J. Kimble Frazer, MD, PhD, Phillip Barnette, MD, Joshua D. Schiffman, MD

Blood (2010) 116 (21): 273.

https://doi.org/10.1182/blood.V116.21.273.273

Published: 2010

Journal Articles

High Resolution Genome-Wide Copy Number Analysis of Pediatric Burkitt Lymphoma Identifies Copy Number Alterations In the Majority of Patients

Joshua D. Schiffman, MD, Patrick D. Lorimer, BS, Vladimir Rodic, BS, Mona S. Jahromi, BS, Jonathan M. Downie, BS, Michael G. Bayerl, MD, Sherrie L. Perkins, MD, PhD, Phillip Barnette, MD, Rodney R. Miles, MD, PhD

Blood (2010) 116 (21): 3123.

https://doi.org/10.1182/blood.V116.21.3123.3123

Published: 2010

Journal Articles

Novel Use of Molecular Inversion Probes to Interrogate Formalin-Fixed Paraffin-Embedded (FFPE) Samples of Childhood Leukemia.

Schiffman D. Schiffman, MD, Jonathan Downie, BS, Bradley Demarest, MS, Roberto Montenegro, PhD, Vladimir Rodic, BS, Phillip Barnette, MD, Rodney R. Miles, MD, PhD

Blood (2009) 114 (22): 1589.

https://doi.org/10.1182/blood.V114.22.1589.1589

Published: 2009

Journal Articles

Pilot Study of Ethnic Variation in Biological Features of Childhood Acute Lymphoblastic Leukemia (ALL) in Utah.

Roberto Montenegro, PhD, Nancy Vu, BS, Mona Jahromi, BS, Kenneth Boucher, PhD, Rodney R. Miles, MD, PhD, Phillip Barnette, MD, Joshua D. Schiffman, MD

Blood (2009) 114 (22): 4117.

https://doi.org/10.1182/blood.V114.22.4117.4117

Published: 2009

Journal Articles

Retrospective Survey of Children Treated for Relapsed Acute Lymphoblastic Leukemia (Complete Remission (CR) Rates): A Report from the Therapeutic Advances in Childhood Leukemia (TACL) Consortium.

Richard H. Ko, MD, Lingyun Ji, MS, Richard Sposto, PhD, Phillip Barnette, MD, Bruce Bostrom, MD, Raymond Hutchinson, MD, Elizabeth Raetz, MD, Nita Seibel, MD, Clare Twist, MD, Elena Eckroth, BA, Paul Gaynon, MD, Mignon Loh, MD

Blood (2007) 110 (11): 854.

https://doi.org/10.1182/blood.V110.11.854.854

Published: 2007

NARROW

Pediatric Patients with Relapsed/Refractory Acute Lymphoblastic Leukemia Harboring Heterogeneous Genomic Profiles Respond to Venetoclax in Combination with Chemotherapy

Pegylated E. coli Asparaginase Desensitization: An Effective and Feasible Option for Pediatric Patients with Acute Lymphoblastic Leukemia Who Have Developed Hypersensitivity to Pegaspargase in the Absence of Asparaginase Erwinia Chrysanthemi availability

CA180-372: An International Collaborative Phase 2 Trial of Dasatinib and Chemotherapy in Pediatric Patients with Newly Diagnosed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ ALL)

Initial Results from a Phase 2 Study of Blinatumomab in Pediatric Patients with Relapsed/Refractory B-Cell Precursor Acute Lymphoblastic Leukemia

IKZF1 and 22q11.22 Deletions and PDGFRA Gains Are Associated with Poor Outcome in Down Syndrome Acute Lymphoblastic Leukemia

Interim Report of a Randomized, Open-Label, Multicenter Study to Evaluate the Safety and Efficacy of Decitabine As an Epigenetic Priming Agent When Combined with Induction Chemotherapy in Pediatric Patients (pts) with Newly Diagnosed Acute Myelogenous Leukemia (AML)

PTEN Expression Is Decreased in Pediatric Burkitt Lymphoma Tissues but Does Not Correlate with AKT Activation.

Focal 22q11.22 Loss Combined with IKZF1 Alterations Predict Very Poor Outcome in Childhood Acute Lymphoblastic Leukemia

T-Cell Receptor Gene Deletions Are Associated with High Risk Features and Worse Outcome In Childhood Precursor B-Cell Acute Lymphoblastic Leukemia (ALL)

VPREB1 Deletions Occur Independent of Lambda-Light Chain Rearrangement and Predict Worse Outcome In Pediatric Acute Lymphoblastic Leukemia (ALL)

High Resolution Genome-Wide Copy Number Analysis of Pediatric Burkitt Lymphoma Identifies Copy Number Alterations In the Majority of Patients

Novel Use of Molecular Inversion Probes to Interrogate Formalin-Fixed Paraffin-Embedded (FFPE) Samples of Childhood Leukemia.

Pilot Study of Ethnic Variation in Biological Features of Childhood Acute Lymphoblastic Leukemia (ALL) in Utah.

Retrospective Survey of Children Treated for Relapsed Acute Lymphoblastic Leukemia (Complete Remission (CR) Rates): A Report from the Therapeutic Advances in Childhood Leukemia (TACL) Consortium.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only